US 6579893
Use of troglitazone and related compounds for the treatment of cancer
expired A61KA61K31/426A61K31/427
Quick answer
US patent 6579893 (Use of troglitazone and related compounds for the treatment of cancer) held by The Board of Regents of the University of Texas System expires Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 17 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/426, A61K31/427, A61K31/4439, A61P